CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade Sensus Healthcare, Inc. - SRTS CFD

    -
    0%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread -
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.024874%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		0.002651%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 20%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* N/A
    Open* N/A
    1-Year Change* N/A
    Day's Range* N/A
    52 wk Range 4.80-15.25
    Average Volume (10 days) 125.62K
    Average Volume (3 months) 4.83M
    Market Cap 80.31M
    P/E Ratio 3.36
    Shares Outstanding 16.39M
    Revenue 44.53M
    EPS 1.46
    Dividend (Yield %) N/A
    Beta 0.67
    Next Earnings Date May 3, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low

    Sensus Healthcare, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 44.532 27.042 9.57693 27.2633 26.4272
    Revenue 44.532 27.042 9.57693 27.2633 26.4272
    Cost of Revenue, Total 14.904 10.054 4.32784 9.7061 9.5163
    Gross Profit 29.628 16.988 5.24909 17.5571 16.9109
    Total Operating Expense 29.701 22.922 16.465 29.2315 28.4325
    Selling/General/Admin. Expenses, Total 11.337 9.432 9.32554 13.1078 12.6558
    Research & Development 3.46 3.436 4.15743 6.41762 6.26041
    Operating Income 14.831 4.12 -6.88808 -1.96829 -2.00535
    Interest Income (Expense), Net Non-Operating 0.38 0 0.05256 0.26829 -0.01741
    Net Income Before Taxes 27.99 4.119 -6.83553 -1.7 -2.02276
    Net Income After Taxes 24.244 4.119 -6.83553 -1.7 -2.02276
    Net Income Before Extra. Items 24.244 4.119 -6.83553 -1.7 -2.02276
    Net Income 24.244 4.119 -6.83553 -1.7 -2.02276
    Total Adjustments to Net Income
    Income Available to Common Excl. Extra. Items 24.244 4.119 -6.83553 -1.7 -2.02276
    Income Available to Common Incl. Extra. Items 24.244 4.119 -6.83553 -1.7 -2.02276
    Diluted Net Income 24.244 4.119 -6.83553 -1.7 -2.02276
    Diluted Weighted Average Shares 16.6182 16.5031 16.4341 16.2327 14.1158
    Diluted EPS Excluding Extraordinary Items 1.45888 0.24959 -0.41594 -0.10473 -0.1433
    Diluted Normalized EPS 0.79282 0.25783 -0.49783 -0.10473 -0.1433
    Total Extraordinary Items
    Unusual Expense (Income) 0 -1.34579
    Gain (Loss) on Sale of Assets 12.779 -0.001
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 13.105 9.01 12.08 10.338 13.025
    Revenue 13.105 9.01 12.08 10.338 13.025
    Cost of Revenue, Total 4.754 3.136 3.824 3.189 4.169
    Gross Profit 8.351 5.874 8.256 7.149 8.856
    Total Operating Expense 8.932 6.849 7.51 6.408 7.706
    Selling/General/Admin. Expenses, Total 3.02 2.967 2.859 2.491 2.431
    Research & Development 1.158 0.746 0.827 0.728 1.106
    Operating Income 4.173 2.161 4.57 3.93 5.319
    Interest Income (Expense), Net Non-Operating 0.235 0.118 0.024 0.001 0
    Net Income Before Taxes 4.408 2.279 4.594 16.71 5.318
    Net Income After Taxes 2.831 1.829 3.524 16.062 5.318
    Net Income Before Extra. Items 2.831 1.829 3.524 16.062 5.318
    Net Income 2.831 1.829 3.524 16.062 5.318
    Income Available to Common Excl. Extra. Items 2.831 1.829 3.524 16.062 5.318
    Income Available to Common Incl. Extra. Items 2.831 1.829 3.524 16.062 5.318
    Diluted Net Income 2.831 1.829 3.524 16.062 5.318
    Diluted Weighted Average Shares 16.5771 16.595 16.6315 16.6416 16.6018
    Diluted EPS Excluding Extraordinary Items 0.17078 0.11021 0.21189 0.96517 0.32033
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS 0.17078 0.11021 0.21189 0.22705 0.32045
    Unusual Expense (Income) 0
    Gain (Loss) on Sale of Assets 0 0 0 12.779 -0.001
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 31.245 25.1711 34.0032 31.9022 17.8867
    Cash and Short Term Investments 14.519 14.907 15.4897 15.3764 11.1901
    Cash & Equivalents 14.519 14.907 8.10029 12.4843 10.0855
    Short Term Investments 0 7.38941 2.89219 1.10464
    Total Receivables, Net 12.13 3.77594 14.0112 13.1459 4.95826
    Accounts Receivable - Trade, Net 12.13 3.77594 14.0112 13.1459 4.95826
    Total Inventory 1.759 4.42711 2.99712 1.62882 1.17138
    Prepaid Expenses 2.837 2.06104 1.50518 1.75099 0.56697
    Total Assets 32.24 28.0099 36.9245 33.2512 18.8352
    Property/Plant/Equipment, Total - Net 0.774 2.43156 2.48247 0.89103 0.39408
    Property/Plant/Equipment, Total - Gross 2.985 4.29572 3.71273 1.74904
    Accumulated Depreciation, Total -2.211 -1.86416 -1.23027 -0.85801
    Intangibles, Net 0.146 0.33788 0.33735 0.43374 0.53012
    Long Term Investments 0 0
    Other Long Term Assets, Total 0.075 0.06939 0.10156 0.02427 0.02427
    Total Current Liabilities 5.963 4.85609 6.46831 6.02448 7.08183
    Payable/Accrued 4.058 2.87372 4.77944 5.16624 4.06789
    Notes Payable/Short Term Debt 0 0 0 0 2.21497
    Other Current Liabilities, Total 1.68 1.67897 1.37935 0.85824 0.79896
    Total Liabilities 6.225 6.51429 8.92313 6.79121 7.15491
    Total Long Term Debt 0 0.26678 0 0 0
    Other Liabilities, Total 0.262 1.39142 2.45481 0.76673 0.07308
    Total Equity 26.015 21.4956 28.0014 26.46 11.6803
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.167 0.16564 0.1654 0.16146 0.13522
    Additional Paid-In Capital 44.115 43.7009 43.3141 39.9579 23.1816
    Retained Earnings (Accumulated Deficit) -17.942 -22.0611 -15.2255 -13.5255 -11.5028
    Total Liabilities & Shareholders’ Equity 32.24 28.0099 36.9245 33.2512 18.8352
    Total Common Shares Outstanding 16.6173 16.4911 16.4858 16.1125 13.4887
    Treasury Stock - Common -0.325 -0.3099 -0.25257 -0.13382 -0.13382
    Accrued Expenses 0.174 0.30341 0.30952
    Long Term Debt 0 0.26678
    Current Port. of LT Debt/Capital Leases 0.051
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 48.462 31.245 24.469 24.391 23.915
    Cash and Short Term Investments 32.83 14.519 16.391 15.204 13.652
    Cash & Equivalents 32.83 14.519 16.391 15.204 13.652
    Total Receivables, Net 10.54 12.13 4.069 4.579 4.056
    Accounts Receivable - Trade, Net 10.54 12.13 4.069 4.579 4.056
    Total Inventory 2.326 1.759 2.041 3.132 4.298
    Prepaid Expenses 2.766 2.837 1.968 1.476 1.909
    Total Assets 53.929 32.24 25.626 26.362 26.482
    Property/Plant/Equipment, Total - Net 1.564 0.774 0.918 1.708 2.192
    Property/Plant/Equipment, Total - Gross 3.551 2.985 3.036 3.72 4.175
    Accumulated Depreciation, Total -1.987 -2.211 -2.118 -2.012 -1.983
    Intangibles, Net 0.122 0.146 0.17 0.194 0.307
    Other Long Term Assets, Total 3.781 0.075 0.069 0.069 0.068
    Total Current Liabilities 10.262 5.963 4.773 5.154 4.682
    Payable/Accrued 4.418 4.058 2.686 3.026 2.828
    Accrued Expenses 0.185 0.174 0.24 0.307 0.307
    Notes Payable/Short Term Debt 0 0 0.105 0.159 0
    Other Current Liabilities, Total 5.659 1.68 1.742 1.662 1.547
    Total Liabilities 11.471 6.225 5.019 6.147 6.047
    Total Long Term Debt 0 0 0 0 0.213
    Long Term Debt 0 0 0 0.213
    Other Liabilities, Total 1.209 0.262 0.246 0.993 1.152
    Total Equity 42.458 26.015 20.607 20.215 20.435
    Common Stock 0.168 0.167 0.167 0.166 0.166
    Additional Paid-In Capital 44.518 44.115 44.025 43.82 43.761
    Retained Earnings (Accumulated Deficit) -1.88 -17.942 -23.26 -23.455 -23.176
    Treasury Stock - Common -0.348 -0.325 -0.325 -0.316 -0.316
    Total Liabilities & Shareholders’ Equity 53.929 32.24 25.626 26.362 26.482
    Total Common Shares Outstanding 16.6775 16.6173 16.6173 16.4896 16.4896
    Current Port. of LT Debt/Capital Leases 0 0.051
    Preferred Stock - Non Redeemable, Net 0 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line 4.119 -6.83553 -1.7 -2.02276 -3.71051
    Cash From Operating Activities -0.286 -0.43418 -2.10664 -8.56373 -3.05661
    Cash From Operating Activities 0.613 0.72187 0.54572 0.65826 0.38792
    Non-Cash Items 1.12 0.11821 1.34984 1.09115 0.83485
    Cash Interest Paid 0.002 0.01246 0 0.15669 0.04332
    Changes in Working Capital -6.138 5.56127 -2.3022 -8.29038 -0.56886
    Cash From Investing Activities 0.129 7.03086 -4.89781 -2.64239 6.17391
    Capital Expenditures -0.128 -0.35855 -0.40059 -0.85483 -0.28759
    Other Investing Cash Flow Items, Total 0.257 7.38941 -4.49722 -1.78756 6.46151
    Cash From Financing Activities -0.231 0.21001 2.62048 13.6049 1.92568
    Financing Cash Flow Items -0.015 -0.05733 -0.11875 -1.52098 -0.28929
    Total Cash Dividends Paid 0
    Issuance (Retirement) of Stock, Net 0 0.00056 2.73924 17.3409 0
    Issuance (Retirement) of Debt, Net -0.216 0.26678 0 -2.21497 2.21497
    Net Change in Cash -0.388 6.80669 -4.38397 2.39879 5.04299
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line 16.062 4.119 -1.199 -1.394 -1.115
    Cash From Operating Activities 3.082 -0.286 1.494 0.241 -1.115
    Cash From Operating Activities 0.092 0.613 0.472 0.345 0.208
    Non-Cash Items -12.747 1.12 0.683 0.35 0.086
    Changes in Working Capital 3.419 -6.138 1.538 0.94 -0.294
    Cash From Investing Activities 14.956 0.129 0.167 0.17 -0.08
    Capital Expenditures -0.044 -0.128 -0.09 -0.087 -0.08
    Other Investing Cash Flow Items, Total 15 0.257 0.257 0.257 0
    Cash From Financing Activities 0.273 -0.231 -0.177 -0.114 -0.06
    Financing Cash Flow Items -0.023 -0.015 -0.015 -0.006 -0.006
    Issuance (Retirement) of Debt, Net -0.051 -0.216 -0.162 -0.108 -0.054
    Net Change in Cash 18.311 -0.388 1.484 0.297 -1.255
    Cash Interest Paid 0 0.002 0.001 0.001
    Issuance (Retirement) of Stock, Net 0.347 0
    Deferred Taxes -3.744
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Solot (Edwin L) Individual Investor 9.4863 1554845 439736 2022-12-31 LOW
    Sardano (Joseph C) Individual Investor 6.8961 1130293 -41588 2022-09-07 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.437 727236 133365 2022-12-31 LOW
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 4.1027 672456 76837 2022-12-31 MED
    Cohen (Stephen Brad) Individual Investor 4.0913 670585 -160000 2022-04-12 LOW
    Punch & Associates Investment Management, Inc. Investment Advisor/Hedge Fund 3.0353 497500 195160 2022-12-31 LOW
    Hillsdale Investment Management Inc. Investment Advisor/Hedge Fund 2.8689 470232 -74104 2022-12-31 MED
    McCall (William H) Individual Investor 2.1049 345000 -10000 2022-05-10 LOW
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.3777 225806 99340 2022-12-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.1912 195245 0 2022-12-31 LOW
    Renaissance Technologies LLC Hedge Fund 1.0905 178734 -87300 2022-12-31 HIGH
    Empirical Wealth Management Investment Advisor 0.9116 149418 52911 2022-12-31 LOW
    G2 Investment Partners Management LLC Hedge Fund 0.9017 147800 -314375 2022-12-31 HIGH
    Navellier & Associates Inc. Investment Advisor/Hedge Fund 0.7579 124217 6428 2022-12-31 MED
    Newton Investment Management North America, LLC Investment Advisor 0.7527 123370 61870 2022-12-31 MED
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7499 122917 1214 2022-12-31 LOW
    Invenire Capital, LLC Investment Advisor 0.7252 118867 118867 2022-09-30 MED
    O'Rear (Samuel) Individual Investor 0.6929 113570 -50000 2022-08-10 LOW
    D. E. Shaw & Co., L.P. Hedge Fund 0.494 80972 55822 2022-12-31 MED
    Sardano (Michael) Individual Investor 0.4623 75774 6255 2023-01-26 LOW

    Start a global, multi-asset portfolio with an award-winning platform

    Trade now Desktop

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    Sensus Healthcare, Inc. Company profile

    About Sensus Healthcare Inc

    Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100 Plus and SRT-100 Vision. The Company's product, SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its other two products, such as SRT-100 Plus and SRT-100 Vision provides customers with additional options compared to the SRT-100 base model.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Sensus Healthcare Inc revenues increased from $9.6M to $27M. Net income totaled $4.1M vs. loss of $6.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Research and development decrease of 17% to $3.4M (expense), Interest expense decrease of 93% to $1K (expense).

    Industry: Medical Diagnostic & Testing Equipment

    851 Broken Sound Pkwy NW Ste 215
    BOCA RATON
    FLORIDA 33487-3635
    US

    Income Statement

    • Annual
    • Quarterly

    News

    A file photo shows a part of a stack of 500 Canadian gold coins, worth $1 million USD according to Sprott Money, is displayed at the precious metals dealer's booth at the Prospectors and Developers Association of Canada (PDAC) annual conference in Toronto

    PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise

    Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.

    09:37, 31 March 2023
    People use DBS automated teller machines (ATMs) in Singapore March 31, 2022.

    Singapore's DBS has seen inflows in SVB aftermath, CEO says

    DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.

    09:24, 31 March 2023
    Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2023.

    US STOCKS-Futures muted as investors await key inflation data

    U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.

    09:16, 31 March 2023
    A file photo of the logo of Australian energy company Origin pictured in Melbourne, Australia, July 3, 2016

    Asia M&As drop to decade low as tumultuous backdrop deters dealmaking

    Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.

    09:14, 31 March 2023
    A file photo of a worker shoveling coal in a supply truck at a yard on the outskirts of Ahmedabad, India, October 25, 2018.

    Coal India surpasses annual output target for first time in 17 years

    Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.

    09:13, 31 March 2023
    A file photo of bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019.

    Global IPOs marred by banks and recession enjoy few bright spots

    A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.

    09:06, 31 March 2023
    A file photo of Unicredit Bank logo seen in this illustration taken March 12, 2023.

    UniCredit shareholders gather to vote on CEO's new pay scheme

    Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.

    09:04, 31 March 2023

    People also watch

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Long position overnight fee -0.0156%
    Short position overnight fee -0.0063%
    Overnight fee time 21:00 (UTC)
    Spread 0.03

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Long position overnight fee -0.0249%
    Short position overnight fee 0.0027%
    Overnight fee time 21:00 (UTC)
    Spread 3.0

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Long position overnight fee -0.0185%
    Short position overnight fee 0.0102%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Long position overnight fee -0.4092%
    Short position overnight fee 0.3873%
    Overnight fee time 21:00 (UTC)
    Spread 0.005

    Still looking for a broker you can trust?

    Join the 500.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading